KRN7000 applied to melanoma research

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells

Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

New 7DW8-5 glycolipid

7DW8-5

Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch

 

Meet Funakoshi Company
at the following meetings:



ASCB
Philadelphia, PA
December 2-6, 2017